首頁 > 市場調查報告書 > 通訊

IT安全性

市場調查報告書

商品編碼

1917795

醫療保健電子知情同意市場－2026-2031年預測

eConsent in Healthcare Market - Forecast from 2026 to 2031

出版日期: 2026年01月06日 | 出版商:

Knowledge Sourcing Intelligence | 英文 150 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計醫療保健電子同意市場將從 2025 年的 651,034,000 美元成長到 2031 年的 1,224,730,000 美元，複合年成長率為 11.11%。

醫療保健電子知情同意市場代表著病患知情同意管理方式的根本性轉變，它從基於紙本的行政流程轉向融入病人參與和臨床工作流程的數位化元素。電子知情同意是指利用數位平台取得病患對醫療程序、治療或研究參與的知情同意，該平台用於呈現資訊、確認理解並取得簽名。在醫療保健領域更廣泛的數位轉型、不斷變化的法規以及電子知情同意在提高營運效率和以患者為中心的護理方面已被證實具有的價值的推動下，該市場正經歷著穩步成長。

主要成長要素

它具備多項強大的優勢，可加速醫療機構的採用。電子知情同意平台透過影片、測驗和分層資訊等互動式多媒體元素，提升病患的理解和參與度，這些元素已被證明比靜態紙本表格更能有效提高理解力。對於醫療機構而言，知情同意書的數位化顯著提高了營運效率，因為它消除了與列印、儲存和管理紙本文件相關的成本和後勤負擔。與電子健康記錄 (EHR) 系統的整合實現了知情同意書的無縫記錄和即時搜尋，從而簡化了臨床工作流程並減少了行政工作。此外，電子知情同意還支持遠距收集知情同意，這對於擴大患者就醫管道、支持遠端醫療舉措以及實現不受地域限制的臨床試驗參與至關重要。

醫療保健生態系統中數位科技的日益普及是推動市場發展的因素。該行業正在進行的數位革命，強調利用技術改進醫療服務和營運流程，為電子知情同意書的推廣應用創造了理想的環境。電子知情同意書取代了紙本工作流程，符合數位化和自動化行政任務的策略性舉措，從而提高了數據的準確性、安全性和可近性。

政府的支持性法規和指導方針為市場擴張提供了關鍵框架。主要市場的監管機構已發布指南，建議在臨床護理和研究中使用電子系統來取得知情同意。這些指南使電子知情同意的使用合法化，明確了合規要求，並鼓勵醫療服務提供者和研究贊助商採用標準化的數位化解決方案。這種監管核准對於建立機構信任和加速採購決策至關重要。

在臨床試驗中，電子知情同意書（eConsent）正日益成為招募、促進和留住受試者的重要工具。透過以引人入勝、易於理解的方式呈現複雜的試驗訊息，受試者能夠更深入地了解通訊協定、風險和益處。文件管理、遠端註冊和監管審核效率的提升正在改變試驗運作方式，使得電子知情同意書成為申辦方和合約研究組織（CRO）提升研究效率和資料品質的策略性投資。

市場挑戰與限制因素

儘管成長要素強勁，但仍有一些限制阻礙市場擴張。其中一個主要挑戰是，將電子知情同意平台與現有醫療IT基礎設施（例如電子健康記錄（EHR）和臨床試驗管理系統）整合存在技術和營運方面的難題。確保無縫互通性通常需要大量的IT資源和周詳的計劃管理。

數位無障礙和數位素養方面也存在障礙。對於某些患者群體，例如老年人或技術能力有限的人，數位知情同意流程可能具有挑戰性。因此，電子知情同意系統必須具備強大的無障礙功能，並提供其他選擇，例如當面或輔助式數位知情同意，以確保公平獲取資訊並遵守知情同意原則。此外，依賴供應商開發和維護平台可能會使部署計劃和後續系統管理變得複雜。

區域市場動態

預計北美將佔據全球市場的重要佔有率。這一主導地位歸功於該地區醫療保健領域數位技術的高普及率、成熟且活躍的臨床試驗體系，以及完善的醫療設施和研究機構基礎設施。此外，主要電子知情同意軟體供應商的存在以及積極推動數位知情同意的法規環境也進一步促進了技術的普及。這些因素共同造就了電子知情同意解決方案需求和創新的集中中心。

競爭格局

競爭格局的特點是，專業技術供應商提供基於雲端的平台，以滿足醫療保健和臨床研究的嚴格要求。主要企業憑藉深厚的領域專業知識、與電子健康記錄 (EHR) 和臨床試驗平台等關鍵系統的整合能力以及對合規性的重視而脫穎而出。解決方案涵蓋從生命科學領域全面的內容和資料管理套件到用於臨床試驗文件管理和病人參與的特定工作流程平台。在這個市場取得成功取決於能否展現安全性、可靠性以及對醫護人員和病患都友善的使用者體驗。

總之，醫療保健電子知情同意市場正從單純的便利措施發展成為數位健康策略的核心要素。其成長與整個醫療保健產業向數位化、病患賦權和營運效率提升的轉型密不可分。產業專家關注的重點在於開發真正可互通的平台，最大限度地減少整合負擔；為不同患者群體設計包容且易於使用的使用者體驗；以及不斷適應全球市場不斷變化的監管標準。從長遠來看，電子知情同意將成為醫療服務的標準流程，是現代臨床實踐和研究的重要組成部分。

本報告的主要優勢：

深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略打入市場的潛力。
市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及其影響、新產品開發、競爭影響

分析範圍

歷史資料（2021-2025 年）和預測資料（2026-2031 年）
成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
競爭對手定位、策略和市場佔有率分析
按業務板塊和地區（國家）分類的收入成長和預測分析
公司概況（策略、產品、財務資訊、關鍵趨勢等）

The eConsent in healthcare market represents a fundamental shift in the administration of patient consent, moving from a paper-based, administrative task to an integrated, digital component of patient engagement and clinical workflow. eConsent refers to the electronic process of obtaining and documenting a patient's informed permission for medical procedures, treatments, or research participation, utilizing digital platforms to present information, verify comprehension, and capture signatures. This market is experiencing steady growth, driven by the broader digital transformation of healthcare, regulatory evolution, and the demonstrated value of eConsent in improving operational efficiency and patient-centric care.

Primary Growth Catalysts

Multiple compelling benefits are accelerating adoption across healthcare settings. eConsent platforms enhance patient comprehension and engagement through interactive multimedia elements, such as videos, quizzes, and layered information, which are proven to improve understanding compared to static paper forms. For healthcare organizations, the digitization of consent generates significant operational efficiencies by eliminating the costs and logistical burdens associated with printing, storing, and managing physical documents. Integration with Electronic Health Record (EHR) systems enables seamless documentation and immediate retrieval of consent forms, streamlining clinical workflows and reducing administrative overhead. Furthermore, eConsent facilitates remote consent acquisition, which is critical for expanding patient access, supporting telehealth initiatives, and enabling participation in clinical trials without geographic constraints.

The increased implementation of digital technology across the healthcare ecosystem serves as a foundational market driver. The sector's ongoing digital revolution, emphasizing the use of technology to improve care delivery and operational processes, creates a natural environment for eConsent adoption. By replacing paper-based workflows, eConsent aligns with strategic initiatives to digitize and automate administrative functions, thereby enhancing data accuracy, security, and accessibility.

Supportive government regulations and guidance are providing a critical framework for market expansion. Regulatory bodies in key markets have issued guidelines endorsing the use of electronic systems for obtaining informed consent in both clinical care and research. These directives validate the use of eConsent, clarify compliance requirements, and encourage healthcare providers and research sponsors to adopt standardized digital solutions. This regulatory endorsement is crucial for building institutional confidence and accelerating procurement decisions.

Within clinical trials, eConsent is becoming an increasingly vital tool for enhancing participant recruitment, comprehension, and retention. The ability to present complex trial information in an engaging, accessible format improves participant understanding of protocols, risks, and benefits. The efficiency gains in document management, remote enrollment, and regulatory auditing are transforming trial operations, making eConsent a strategic investment for sponsors and Contract Research Organizations (CROs) aiming to streamline studies and improve data quality.

Market Challenges and Constraints

Despite strong growth drivers, several restraints temper market expansion. A significant challenge is the technical and operational difficulty of integrating eConsent platforms with existing healthcare IT infrastructure, such as EHRs and clinical trial management systems. Successful implementation often requires substantial IT resources and careful project management to ensure seamless interoperability.

The market also faces hurdles related to digital accessibility and literacy. Certain patient populations, including older adults or those with limited technological proficiency, may find digital consent processes challenging. This necessitates that eConsent system designs incorporate robust accessibility features and provide alternative pathways, such as in-person or assisted digital consent, to ensure equitable access and maintain compliance with informed consent principles. Furthermore, reliance on third-party vendors for platform development and maintenance can lead to complexities in deployment timelines and ongoing system management.

Geographic Market Dynamics

North America is projected to hold a significant share of the global market. This leadership position is attributed to the region's higher rate of digital technology adoption in healthcare, a mature and active clinical trials sector, and a well-established infrastructure of healthcare facilities and research institutions. The presence of leading eConsent software providers and a regulatory environment that has actively provided guidance on digital consent further catalyzes adoption. These factors combine to create a concentrated hub of demand and innovation for eConsent solutions.

Competitive Landscape

The competitive environment features specialized technology providers offering cloud-based platforms tailored for the rigorous demands of healthcare and clinical research. Key companies differentiate themselves through deep domain expertise, the ability to integrate with critical systems like EHRs and clinical trial platforms, and a focus on regulatory compliance. Solutions range from comprehensive content and data management suites for life sciences to specific workflow platforms for managing clinical trial documentation and patient engagement. Success in this market is contingent on demonstrating security, reliability, and a user-friendly experience for both healthcare professionals and patients.

In conclusion, the eConsent in healthcare market is evolving from a novel convenience to a core component of digital health strategy. Its growth is inextricably linked to the sector's broader move towards digitization, patient empowerment, and operational efficiency. For industry experts, the critical focus areas are the development of truly interoperable platforms that minimize integration burden, the design of inclusive and accessible user experiences for diverse patient populations, and the continuous alignment with evolving regulatory standards across global markets. The long-term trajectory points to eConsent becoming an embedded standard of care, essential for modern clinical practice and research.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2021 to 2025 & forecast data from 2026 to 2031
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

eConsent in Healthcare Market Segmentation

By Process Type
Remote
In-Person
By Media Type
Smartphone
Tablets
Others
By Application
Clinical Trials & Procedures
Medical Treatment
By Geography
North America
United States
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. ECONSENT IN HEALTHCARE MARKET BY PROCESS TYPE

5.1. Introduction
5.2. Remote
5.3. In-Person

6. ECONSENT IN HEALTHCARE MARKET BY MEDIA TYPE

6.1. Introduction
6.2. Smartphone
6.3. Tablets
6.4. Others

7. ECONSENT IN HEALTHCARE MARKET BY APPLICATION

7.1. Introduction
7.2. Clinical Trials & Procedures
7.3. Medical Treatment

8. ECONSENT IN HEALTHCARE MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. USA
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. Germany
- 8.4.2. France
- 8.4.3. United Kingdom
- 8.4.4. Spain
- 8.4.5. Others
8.5. Middle East and Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Others
8.6. Asia Pacific
- 8.6.1. China
- 8.6.2. India
- 8.6.3. Japan
- 8.6.4. South Korea
- 8.6.5. Indonesia
- 8.6.6. Thailand
- 8.6.7. Others